openPR Logo
Press release

Middle East & Africa Gastroparesis Market will grow by US$ 278.36 million during 2020-2027, according to Business Market Insights

09-20-2021 11:18 AM CET | Health & Medicine

Press release from: Business Market Insights

Gastroparesis Market 2028

Gastroparesis Market 2028

The Gastroparesis Market in MEA is expected to grow from US$ 230.20 million in 2020 to US$ 278.36 million by 2027; it is estimated to grow at a CAGR of 2.8% from 2020 to 2027.

MEA consists of three major countries namely United Arab Emirates (UAE), Saudi Arabia and South Africa. Saudi Arabia is the largest market for gastroparesis. The market is driven by extensive research projects undertaken by a number of research institutes, rising prevalence of gastroparesis, and availability of infrastructure and facilities for research in UAE and Saudi Arabia. Rest of MEA include countries such as, Israel, Iran, Iraq, Kuwait, Oman, Egypt, Kenya, and others.

Browse Full Report-https://www.businessmarketinsights.com/reports/middle-east-and-africa-gastroparesis-market

Gastric emptying is associated with the coordination among the motor activity of proximal stomach, distal stomach, and duodenum. These internal organs are controlled by the feedback mechanism from neural signals generated through the interaction between nutrients and small intestine. Aging leads to diminished homeostatic regulations of physiologic functions, along with the slowing of gastric emptying.

Get Sample Copy of this Middle East & Africa Gastroparesis Market research report at - https://www.businessmarketinsights.com/sample/TIPRE00024819

Major Key players covered in this report:
• Allergan Plc
• Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
• Ipca Laboratories Ltd.
• Johnson and Johnson Services, Inc.
• Pfizer Inc.
• TEVA PHARMACEUTICAL INDUSTRIES LTD

Market Segmentation

MEA Gastroparesis Market - By Type

1. Idiopathic
2. Diabetic
3. Post-surgical
4. Others

MEA Gastroparesis Market - By Drug Class

1. Prokinetic Agents
2. Botulinum Toxin Injections
3. Antiemetic Agent

MEA Gastroparesis Market – By Distribution Channel

1. Hospital Pharmacies
2. Retail Pharmacies
3. Others

Order a Copy of this Middle East & Africa Gastroparesis Market research report at – https://www.businessmarketinsights.com/buy/single/TIPRE00024819

The COVID-19 has shown substantial effects in MEA. The COVID-19 pandemic has caused massive disruptions to global supply chains and affected the research and development activities in these countries in 2020. The companies are preferring non-physical marketing campaigns and shifting sales processes online. The COVID-19 has affected the sales of essential OTC drugs such as anti-emetic and prokinetic drugs.

Contact US:

Business Market Insights
Phone: +442081254005
E-Mail ID: sales@businessmarketinsights.com
Web URL: https://www.businessmarketinsights.com/
LinkedIn URL: https://www.linkedin.com/company/business-market-insights/

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Middle East & Africa Gastroparesis Market will grow by US$ 278.36 million during 2020-2027, according to Business Market Insights here

News-ID: 2398786 • Views: 271

More Releases from Business Market Insights

Chromatography Resin Market 2022 Introduction, Definition, Demand, Opportunities …
The Chromatography Resin market crossed US$ 1.5 billion mark in 2022 and is expected to hit US$ 3.37 billion by 2030, recording a CAGR of 20.33% during the forecast period. Chromatography Resin Market Report 2022 is a professional and in-depth survey on the current state of the Chromatography Resin Market. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Chromatography Resin Market
3D Printing Plastics Market Industry Analysis, Growth Opportunities, Future Dema …
The 3D Printing Plastics market crossed US$ 750 million mark in 2022 and is expected to hit US$ 3737 million by 2030, recording a CAGR of 22% during the forecast period. 3D Printing Plastics Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Get a Sample Copy of the Report@:
Blood Testing Market is Anticipated to reach $157.40 billion by 2030: Business M …
The Blood Testing market crossed the US$ 89.36 billion mark in 2022 and is expected to hit US$ 157.40 billion by 2030, recording a CAGR of 7.3% during the forecast period. The population is undergoing many lifestyle changes leading to a steady rise in the prevalence of chronic medical conditions. The constant urbanization and the rapid growth in the middle-class population have added substantially to the increase of the sedentary lifestyle
With 9.0% of CAGR, Allergy Diagnostics and Treatment Market to Gain $10.92 Billi …
The Allergy Diagnostics and Treatment market crossed the US$ 5.48 billion mark in 2022 and is expected to hit US$ 10.92 billion by 2030, recording a CAGR of 9.0% during the forecast period. The growing prevalence of allergic disorders demands allergy immunotherapy, a safe and effective treatment against allergens such as pollen, insect molds, animals, and allergic asthma. As per the data of the National Center for Health Statistics survey carried

All 5 Releases


More Releases for Gastroparesis

Gastroparesis Drugs Market Analysis by 2020-2025
Scope of the Report: The worldwide market for Gastroparesis Drugsis expected to grow at a CAGR of roughly x% over the next five years, will reach x million US$ in 2024, from x million US$ in 2019, according to a new Global Info Researchstudy. The report presents the market outlook for the Indian Phospho Gypsum product from the year 2019 to the year 2025. The report provides a definition of the product.
Gastroparesis Drugs Market - Use of Gastroparesis Drugs Is Highest In North Amer …
The Gastroparesis Drugs Market is projected to reach $ 6,448.6 billion, an average annual rate of 4.7% from 2017 to 2023. Gastric paralysis affects the normal spontaneous movement of the gastrointestinal muscles and interferes with normal digestion, causing problems related to nausea, vomiting and blood sugar levels and nutrition. Gastroparesis can be caused by diabetes or after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, and anti-vomiting have been developed to
Diabetic Gastroparesis-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the “Diabetic Gastroparesis-Pipeline Review H1 2017” this report provides an overview of the Diabetic Gastroparesis-Pipeline landscape.  Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts
Diabetic Gastroparesis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Diabetic Gastroparesis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H2 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels
Gastroparesis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status
Diabetic Gastroparesis - Pipeline Market Research Report, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Diabetic Gastroparesis - Pipeline Insight, 2017”. This report provides comprehensive insights about pipeline drugs across this Diabetic Gastroparesis. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Diabetic Gastroparesis. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1214082 This report provides information on the therapeutic development for